Consumer

Healthy.io, a healthtech venture that already has offices in Israel, the UK, and the US, is expanding operations across MENA via a new partnership with the UAE’s Seed Group.

During the first six months of the pandemic, 13% of outpatient visits were conducted through telehealth. By March to August 2021, that number slipped to 8%.

A study published in JAMA Network Open found CCBT led to improved depressive symptoms in primary care patients compared with treatment as usual alone.

The continuous glucose monitoring system can be used to measure glucose levels in adults with diabetes for up to six months.

The Egyptian non-profit has teamed up with GE Healthcare to utilise AI to assess how well a patient is responding to neoadjuvant therapy, commonly used prior to surgery.

This week's top stories include racial and ethnic minority enrollees reporting significantly worse experiences around care access compared to whites, and Amazon Care expanding in-person offerings to 20 new cities.

Berlin-based digital health company plans to expand in the US market.

Biofourmis Care currently includes programs for heart failure, hypertension, diabetes, lipid management and atrial fibrillation.

The tech and retail giant said in-person offerings will be available in more than 20 new cities in 2022, including San Francisco, Miami, Chicago and New York.

Also: Emerging market-focused Reliance Health raises $40 million, insomnia startup Dawn Health rakes in a $1.8 million pre-seed and birth control startup Twentyeight Health adds more Spanish language support.